ABSTRACT. In the adult, atrial natriuretic peptide (ANP) regulates renal and cardiovascular function when blood volume is expanded, when atrial pressure is increased, and when arterial oxygen content is decreased. In late gestation fetal sheep, plasma ANP concentrations are higher than in pregnant adults; however, ANP function in the fetus is unclear. To assess the possible role of ANP in mediating changes in pulmonary blood flow, we studied six chronically cannulated fetal sheep at 132-134 d gestation (term 145 d). We infused ANP in doses of 4.0 + 0.48, 16.0 f
1.9, and 64.0 + 7.7 ng/kg/min, and vehicle into all fetuses.
ANP increased hematocrit, which suggests that blood volume decreased. Pulmonary blood flow, measured by the radionuclide-labeled microsphere technique, increased in response to the 4.0, 16.0, and 64.0 ng/kg/min dose ANP infusions from a control value of 126.5 f 32.2 to 141.8 f 26.9 to 170.4 + 37.2 to 300.8 f 84.8" mL/min/100 g (*p < 0.05), respectively, and calculated pulmonary vascular resistance decreased from a control value of 0.45 2 0.08 to 0.42 + 0.08 to 0.43 f 0.09 to 0.21 + 0.04" (*p < 0.05) mm Hg/mL/min/kg, respectively. Pulmonary blood flow decreased to 54.5 2 6.0 mL/min/100 g and calculated pulmonary vascular resistance increased to 0.81 f 0.09 mm Hg/mL/min/kg during the recovery period. Mean pulmonary and carotid arterial blood pressures, venous blood pressure, and heart rate did not change significantly. Thus, ANP may play a role in maintaining right ventricular output in the fetus by increasing pulmonary blood flow through its ability to decrease pulmonary vascular resistance. (Pediatr Res 27: 140-143, 1990) Abbreviations nary effects (4, 5) . Large doses of ANP cause diuresis and natriuresis ( 9 , a decrease in arterial blood pressure and cardiac output (6) , inhibition of renin secretion after a decrease in renal perfusion pressure (7) , inhibition of aldosterone and vasopressin secretion in vitro (5) , and pulmonary vasodilation after chronic hypoxemia (4) .
ANP is present in fetal cardiac atria, ventricles (8) , and lungs (9); because gas exchange does not occur in the fetal lung, the latter finding suggests that ANP may play a role in regulating the pulmonary vasculature in the fetus. Basal arterial plasma ANP concentrations are greater in the fetus than in the pregnant adult and increase further after volume expansion and acute hypoxemia (10, 11) . Increases in plasma ANP concentrations within a physiologic range decrease combined ventricular output and umbilical-placental blood flow (12), but do not significantly alter mean arterial blood pressure or heart rate (12, 13) . At present, relatively little is known about the effects of ANP on the fetal pulmonary vasculature. Because changes in circulatory dynamics stimulate ANP secretion in the fetus, we considered that the release of ANP into the circulation might play a role in regulating blood flow distribution by changing pulmonary blood flow. To more closely examine the relationships between plasma ANP concentrations and pulmonary blood flow in the fetus, we infused ANP into fetal sheep and measured pulmonary blood flow.
MATERIALS AND METHODS
Surgical procedures. Pregnant ewes were fasted for 24-36 h before surgery (protocol approved by the Committee on Animal Research, UCSF). Epidural anesthesia was induced by injecting 4 mL tetracaine HC1 (Pontocaine HC1, Breon Laboratories, New York, NY). A local anesthetic (0.25% lidocaine hydrochloride) ANP, atrial natriuretic peptide was injected subcutaneously before each maternal and fetal skin i.d., inner diameter incision. Polyvinyl catheters (1.3 mm id., 2.3 mm 0.d.) were o.d., outer diameter placed in the left pedal artery and vein of the ewe and advanced to the descending aorta and inferior vena cava, respectively. Ten percent dextrose in 0.9% NaCl solution was infused continuously into the ewe, and ketamine was given intravenously in 5-100 mg amounts every 15-20 min. ANP is a peptide hormone found in the cardiac atria and lungs
The uterus was exposed through a midline incision in the ewe's of many adult mammalian species (1-3). Plasma ANP concen-abdomen. An incision (2.5 cm) was made in the uterus to expose trations increase when extracellular fluid volume is expanded, the fetal hindlimbs. Polyvinyl catheters (0.8 mm i.d., 1.2 mm when atrial pressure is increased (I), and when arterial oxygen 0.d.) were placed in a pedal vein and artery and advanced, content is decreased (4). Increased plasma ANP concentrations respectively, to the inferior vena cava for injection of radiohave a variety of renal, cardiovascular, endocrine, and pulmo-nuclide-labeled microspheres and to the descending aorta for measurement of arterial blood pressure and withdrawal of blood polyvinyl tubing] was placed in the pulmonary artery for the measurement of pulmonary arterial pressure and for withdrawal of both a microsphere reference sample and blood samples for chemical analysis. Details of this procedure have been described elsewhere (14) . Briefly, a suture was placed in the adventitial layer of the pulmonary trunk midway between the pulmonary valve and the origin of the ductus arteriosus, and the catheter inserted and secured in place by tying the suture around the polyvinyl ring. The same type of catheter described above was placed in the left atrium for the measurement of left atrial pressure and for withdrawal of blood samples. In addition, an electromagnetic flow transducer was placed around the left pulmonary artery. The thoracotomy was closed.
The fetal neck was exposed through the same uterine incision. Polyvinyl catheters (0.8 mm i.d., 1.2 mm 0.d.) were inserted into the carotid artery and jugular vein and advanced to the ascending aorta for withdrawal of blood samples and to the superior vena cava for the infusion of ANP.
All incisions were sutured, and all catheters and the electromagnetic flow transducer cord were exteriorized at the maternal flank and placed in a cloth pouch for protection. At the end of surgery and daily thereafter, antibiotics were placed in the amniotic sac and given intravenously to the ewe (100 mg gentamicin and 1 million U penicillin G). Antibiotics were not given on the day of the experiment. All animals were allowed at least 2 d to recover from surgery before any experiments were performed. All ewes were housed in individual cages and allowed free access to food and water.
Experimental protocol. We studied six chronically cannulated fetuses at gestational ages of 132-134 d (term 145 d). We infused ANP and vehicle (5% dextrose in 0.9% NaCl) into the superior vena cava of all fetuses.
On the day of the experiment, the ewe was placed in a mobile cart, brought to the laboratory, and allowed at least 1 h to acclimate to its surroundings. The catheters were opened and filled with fresh heparin-saline solution, and the electromagnetic flow transducer connected to the flow meter. Fetal arterial pressure, amniotic pressure, left pulmonary artery blood flow, and heart rate were monitored throughout the experiments (the pressures with Statham P23Db strain gauge transducers and flow with a Statham SP2202 meter, Statham Instruments, Oxnard, CA) and recorded continuously on a Beckman recorder (Beckman Instruments, Inc., Palo Alto, CA). Fetal heart rate was measured by a cardiotachometer triggered by an arterial pulse wave. All fetal arterial pressures were corrected to amniotic fluid pressure as zero reference.
The 150-min experiment was divided into a 30-min control period, three 30-min ANP infusion periods, and a 30-min recovery period. ANP (hANP 1-28, Peninsula Laboratories, Belmont, CA; 0.1 mL/min) was infused at 16,64, and 256 ng/min (selected randomly). Fetal wt ranged from 3.3 to 4.6 kg (4.1 t 0.21 kg, mean t SE). Corrected for body wt, the infused doses of ANP were 4.0 + 0.48, 16.0 f 1.9, and 64.0 t 7.7 ng/kg/min. Each animal also received a 30-min infusion of 5% dextrose in 0.9% NaCl at 0.1 mL/min and served as its own control.
During control, infusion, and recovery periods, pulmonary and carotid arterial and left atrial blood samples were collected (3 mL). Blood samples were collected in heparinized syringes, placed in tubes containing EDTA (6 mg) and aprotinin (Trasylol 150 KIU/mL), and immediately placed on ice. The plasma was separated and stored frozen at -70°C until extraction.
At the end of the control period, each infusion period, and the recovery period, radionuclide-labeled microspheres were injected for determination of pulmonary flow as described previously (1 5). Briefly, microspheres labeled with one of Is3Gd, 5 7 C~, "41n, 5'Cr, "3Sn, 85Sr, 95Nb, 54Mn, or 65Zn were injected into the inferior vena cava of the fetus while blood was withdrawn from the pulmonary arterial catheter at a rate of 3.88 mL/min (reference sample). The reference sample was collected starting 10 s before the microsphere injection was begun and ending 45 s after the injection was completed. Blood removed for the reference sample and for chemical analysis was replaced with an equal volume of fetal or maternal blood at the time of sampling. At the end of the study, the ewe and fetus were killed with an intravenous injection of sodium pentobarbital, and the fetal lungs were dissected. To calculate lung blood flow, the lungs were incinerated and radioactivity counted in a multichannel pulse analyzer. Blood flow to the lungs was calculated as flowl,,,, = cpm in lungs/cpm in pulmonary artery (Pa) reference sample x flowp, reference sample. These flow measurements and measured mean pulmonary arterial and left atrial pressures were used to calculate pulmonary vascular resistance.
Assays. Plasma atrial natriuretic peptide concentrations were measured by RIA using a kit (Alpha ANP [12' 1] RIA System, Amersham, Arlington Heights, IL). All plasma samples were extracted on C18 columns (Sep Pak, Waters Associates, Milford, MA). Each column was washed with methanol and distilled water. Plasma samples (I mL) were added to the column and eluted with methanol/trifluroacetic acid. The eluates were dried under nitrogen and reconstituted with assay buffer (500 pL). Duplicate 100 pL plasma extract or standard was then assayed. Because all plasma samples were extracted, an extracted standard curve was also prepared using charcoal-treated plasma. The two standard curves were parallel, and intraassay and interassay coefficients of variation were 13 and 22%, respectively (n = 6).
Fetal and maternal arterial blood pH, Pco2, and Po2 were determined on a Corning 158 Blood Gas Analyzer (Corning Medical, Medfield, MA). Blood Hb concentration and arterial blood oxygen saturation were measured on a Radiometer hemoximeter (OSM2, Copenhagen, Denmark). Hematocrit was measured using the microcapillary technique, and plasma protein concentrations were determined by refractometry.
Data analysis. Responses of the measured variables to ANP administration were analyzed by one-way analysis of variance corrected for repeated measures. A Fisher's test was used to determine which means were statistically different from control values. Fetal blood pressure and heart rate values were obtained by averaging five points every 5 min during the last 15 min of the control and the last 15 min of each infusion period. Means were considered to be significantly different if p < 0.05. All data are reported as mean + SE.
RESULTS
Fetal blood gases and pH were within normal limits and did not change during ANP infusion ( the fetus. As shown in Figure 1 , pulmonary arterial plasma ANP concentrations were higher than in carotid arterial or left atrial blood.
With the 4-and 16-ng/kg/min infusions, ANP produced minimal effects on the hemodynamic variables we measured. When plasma ANP concentrations were increased further with the 64-ng/kg/min infusion, we observed a 58% increase in pulmonary blood flow (Fig. 2, upperpanel) and a 44% decrease in calculated pulmonary vascular resistance (Fig. 2, lower panel) . However, mean arterial and venous pressures, left atrial pressure, and heart rate ( Table 2) did not change significantly. Left pulmonary arterial blood flow, continuously monitored with the electromagnetic flow transducer, increased within 2-3 min and thereafter remained constant at each level throughout the 30 min of infusion. Table 1 shows results for hematocrit, plasma protein concentrations, and Hb. At the highest infusion rate only, hematocrit increased from 32.7 + 2.4 to 34.5 f 2.5% ( p < 0.05). Although there was a tendency for Hb and plasma protein concentrations to increase, these changes were not statistically significant. Collectively, these data suggest that ANP decreased blood volume by approximately 3%. During the vehicle infusion no significant changes were observed in plasma ANP concentration, pulmonary blood flow, hematocrit, Hb, or protein concentrations.
DISCUSSION
The doses of ANP used in this study were chosen to increase fetal plasma ANP concentrations within a physiologic range. Previous studies have shown that volume expansion of fetuses with isotonic saline increases plasma ANP concentrations from 115 + 24 to 409 f 72 pg/mL (1 I). Similarly, when fetuses were made severely hypoxemic, plasma ANP concentrations increased from 127 + 13 to 565 pg/mL at the end of hypoxia and to 1490 pg/mL during the recovery period (10) . Thus, ANP doses used in these studies increased fetal plasma ANP concentrations to levels similar to those observed when the fetus was mildly volume expanded, and to ranges observed during marked decreases in arterial oxygen content. Our results demonstrate that the plasma ANP concentrations achieved with the 4 and 16 ng/kg/min infusions were associated with minimal and statistically insignificant changes in pulmonary or cardiovascular function. However, the larger plasma ANP concentration achieved with the 64 ng/kg/min infusion was associated with significant changes in pulmonary blood flow and pulmonary vascular resistance. This implies that acutely, high plasma ANP concentrations are required to effect pulmonary vascular changes in the fetus.
The 64-ng/kg/min ANP infusion increased pulmonary blood flow by 58% and decreased pulmonary vascular resistance by 44%, but did not significantly change mean pulmonary or carotid arterial blood pressures, venous blood pressure, or heart rate. The decrease in pulmonary vascular resistance is in agreement with findings in chronically hypoxemic adults, in which ANP has been shown to decrease pulmonary vascular resistance (4). The mechanism responsible for the increase in pulmonary blood flow and the decrease in pulmonary vascular resistance is not fully understood. A possible explanation for the observed in- Fig. 2 . Effects of ANP infusions on pulmonary blood flow and calculated pulmonary vascular resistance in six fetal lambs. Data are expressed as mean + SE, ' p < 0.05. crease in pulmonary blood flow is the direct effect of ANP on the pulmonary vasculature to decrease pulmonary vascular resistance and to increase pulmonary blood flow. Bianchi et al. (3) have shown that ANP receptors are present in the lung, and the effect seen may have been produced by interaction with these types of receptors, thereby activating guanylate cyclase to produce cyclic GMP, which mediates smooth muscle relaxation (16) . Because the pulmonary vasculature of the fetus is con- (18) who demonstrated that ANP is a direct relaxant of pulmonary artery segments and has potent relaxant effects on isolated segments of pulmonary artery.
In addition, in vivo studies by Tadepalli and Krueger (19) have shown that ANP infusion blunts acute hypoxemia-induced pulmonary vasoconstriction.
Under basal conditions, plasma ANP concentrations were greater in the pulmonary artery than in the carotid artery or left atrium. These data demonstrate that in the sheep fetus the majority of ANP found in the plasma is produced by the right side of the heart and may reflect the higher right ventricular afterload found normally in the fetus. The fact that the plasma ANP concentration was greater in the pulmonary artery than in both the left atrium and carotid artery, suggests that ANP may be removed from the fetal circulation by the lungs. This is in agreement with reports by T u m n and Gillis (20) showing that ANP is cleared by the lungs in adult rabbits.
At birth many changes take place in the fetal circulation. During lung expansion and the initiation of ventilation, pulmonary arterial pressure and pulmonary vascular resistance decrease (2 1, 22) . ANP may play a role in this process; further studies are needed to test this hypothesis. The primary hypothesis behind these studies was that increases in right ventricular afterload, and thereby potential alterations in stroke volume or output (23) , that might occur during stress could be modulated by right-sided ANP release, pulmonary vasodilatation, and thereby adjustments of the afterload. The responses found suggest that this may in fact occur and that ANP may play a role in regulating pulmonary blood flow, and thereby the distribution of right ventricular blood flow, in the stressed fetus through its ability to decrease pulmonary vascular resistance.
